Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ikove Capital is a venture development company founded in 2014 and headquartered in Columbus, Ohio, with additional operations in Miami, Florida. The firm focuses on early-stage investments, particularly in technology commercialization, by partnering with over 20 U.S. research institutions. Ikove Capital has invested a total of $250 million into its portfolio, generating an impressive equity value exceeding $1 billion.
Since its inception, Ikove has aimed to bridge the capital gap between university-funded research and venture capital investments. The firm operates its proprietary program, the Startup Nursery, which supports the growth of startups by providing capital and resources necessary for success. Ikove Capital's strategic partnerships with research institutions enhance its ability to identify and commercialize disruptive technologies.
Ikove Capital invests primarily in early-stage companies, emphasizing technology commercialization. The firm targets pre-seed, seed, and seed-plus stages, providing capital and resources to help startups transition from research to market. The organization collaborates with over 20 universities and research institutions across the United States to source promising technologies for its Startup Nursery.
Through the Startup Nursery, Ikove Capital offers a unique opportunity for external investors to co-invest alongside them in developing high-impact technologies. The firm seeks to identify startups that demonstrate strong potential for growth and innovation, particularly those emerging from university research. Ikove Capital's investment strategy focuses on bridging the gap between research and venture capital funding, ensuring that groundbreaking technologies reach the market effectively.
Ikove Capital has invested in a diverse portfolio of over 10 companies, generating significant equity value. One notable portfolio company is YEEO Eco-Safe, which is developing a line of larvicides using safe, non-toxic, food-grade materials to combat disease-carrying mosquito larvae. This focus on high-impact technologies reflects Ikove's commitment to supporting startups that address critical challenges.
While specific names and descriptions of all portfolio companies are not disclosed, Ikove Capital's investment strategy emphasizes technology commercialization, particularly in sectors emerging from university research. The firm’s total invested capital of $250 million has facilitated the growth of these companies, contributing to an overall equity value exceeding $1 billion.
To pitch to Ikove Capital, founders should email info@ikovecapital.com. It is recommended to include a concise overview of the startup, the technology being developed, and the specific funding needs in the pitch deck.
Ikove Capital operates the Startup Nursery, a program designed to support the growth of startups by allowing external, strategic investors to co-invest alongside Ikove. This initiative focuses on developing high-impact technologies and creating businesses around the best intellectual property funded through university research budgets.
What are Ikove Capital's investment criteria?
Ikove Capital focuses on early-stage companies, particularly those involved in technology commercialization. The firm seeks startups that can bridge the gap between university research and market application.
How can I apply or pitch to Ikove Capital?
Founders can reach out to Ikove Capital via email at info@ikovecapital.com to discuss potential investment opportunities and pitch their ideas.
What makes Ikove Capital different from other venture firms?
Ikove Capital specializes in technology commercialization and partners with over 20 universities to source disruptive technologies. Their proprietary Startup Nursery program allows for co-investment opportunities, enhancing support for startups.
What is the geographic scope of Ikove Capital's investments?
Ikove Capital primarily focuses on investments within North America, leveraging its presence in Ohio and Florida to engage with local research institutions.
What is the typical check size for investments?
While specific check sizes are not disclosed, Ikove Capital invests in early-stage companies, indicating that their funding is tailored to support startups at the pre-seed, seed, and seed-plus stages.
What kind of post-investment involvement does Ikove Capital have?
Ikove Capital provides operational support and resources through its Startup Nursery, helping portfolio companies navigate the challenges of early-stage growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.